The Valley Desk

NCT00963105 · Interventional trial

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Overall registry status Completed

Phase 2

Conditions Relapsed or Refractory Chronic Lymphocytic Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov